Documentos relacionados

1. Experience with ustekinumab in reservoir Crohn's disease.
2. The symptom experience of newly diagnosed Chinese patients with Crohn's disease: A longitudinal qualitative study.
3. Ustekinumab Therapeutic Drug Monitoring-Impact on Clinical Practice: A Multicenter Cross-Sectional Observational Trial.
4. Relationship between ustekinumab trough concentrations and both clinical and biological remission in patients with Crohn's disease.
5. Ustekinumab Trough Concentrations Are Associated with Biochemical Outcomes in Patients with Crohn's Disease.
6. Clinical Update on the Prevention and Management of Postoperative Crohn's Disease Recurrence.
7. Elderly-onset Crohn's disease remarkably responsive to ustekinumab: a case report.
8. Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control group.
9. Preliminary experience of maintenance treatment with intravenous ustekinumab as a rescue treatment for loss of response to subcutaneous doses.
10. Early fecal calprotectin levels at week 8 may guide therapeutic decisions on Ustekinumab therapy in patients with Crohn's disease.